BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 29290818)

  • 21. RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis.
    Wang S; Li Z; Zhu G; Hong L; Hu C; Wang K; Cui K; Hao C
    J Ovarian Res; 2021 Nov; 14(1):154. PubMed ID: 34774079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of miR-193a/b-3p during HPV-induced cervical carcinogenesis contributes to anchorage-independent growth through PI3K-AKT pathway regulators.
    Xu M; Huseinovic A; Jaspers A; Yuan L; Steenbergen RDM
    J Med Virol; 2023 Mar; 95(3):e28589. PubMed ID: 36799263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA NEAT1 promotes the tumorigenesis of colorectal cancer by sponging miR-193a-3p.
    Yu HM; Wang C; Yuan Z; Chen GL; Ye T; Yang BW
    Cell Prolif; 2019 Jan; 52(1):e12526. PubMed ID: 30407674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetically altered miR‑193a‑3p promotes HER2 positive breast cancer aggressiveness by targeting GRB7.
    Tang Y; Yang S; Wang M; Liu D; Liu Y; Zhang Y; Zhang Q
    Int J Mol Med; 2019 Jun; 43(6):2352-2360. PubMed ID: 31017268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-590-3p Targets Cyclin G2 and FOXO3 to Promote Ovarian Cancer Cell Proliferation, Invasion, and Spheroid Formation.
    Salem M; Shan Y; Bernaudo S; Peng C
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/β-catenin signaling and is regulated by miR-133a-3p.
    Zhou Y; Jin Z; Wang C
    Biomed Pharmacother; 2019 Dec; 120():109449. PubMed ID: 31627092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A positive feedback loop between AlkB homolog 5 and miR-193a-3p promotes growth and metastasis in esophageal squamous cell carcinoma.
    Xue J; Xiao P; Yu X; Zhang X
    Hum Cell; 2021 Mar; 34(2):502-514. PubMed ID: 33231844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LAMC2 regulated by microRNA-125a-5p accelerates the progression of ovarian cancer via activating p38 MAPK signalling.
    Zhang D; Guo H; Feng W; Qiu H
    Life Sci; 2019 Sep; 232():116648. PubMed ID: 31301414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
    Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS
    Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA CDKN2B-AS1 interacts with miR-411-3p to regulate ovarian cancer in vitro and in vivo through HIF-1a/VEGF/P38 pathway.
    Wang Y; Huang Y; Liu H; Su D; Luo F; Zhou F
    Biochem Biophys Res Commun; 2019 Jun; 514(1):44-50. PubMed ID: 31014670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
    Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
    Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of long non-coding RNA XIST has anticancer effects on epithelial ovarian cancer cells through inverse downregulation of hsa-miR-214-3p.
    Wang C; Qi S; Xie C; Li C; Wang P; Liu D
    J Gynecol Oncol; 2018 Nov; 29(6):e99. PubMed ID: 30207107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p.
    Nie W; Ge HJ; Yang XQ; Sun X; Huang H; Tao X; Chen WS; Li B
    Cancer Lett; 2016 Feb; 371(1):99-106. PubMed ID: 26655272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA LINC01234 silencing exerts an anti-oncogenic effect in esophageal cancer cells through microRNA-193a-5p-mediated CCNE1 downregulation.
    Ma J; Han LN; Song JR; Bai XM; Wang JZ; Meng LF; Li J; Zhou W; Feng Y; Feng WR; Ma JJ; Hao JT; Shen ZQ
    Cell Oncol (Dordr); 2020 Jun; 43(3):377-394. PubMed ID: 32130660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-193a-3p inhibition of the Slug activator PAK4 suppresses non-small cell lung cancer aggressiveness via the p53/Slug/L1CAM pathway.
    Liu X; Min S; Wu N; Liu H; Wang T; Li W; Shen Y; Zhao C; Wang H; Qian Z; Xu H; Chen Y; Wang X
    Cancer Lett; 2019 Apr; 447():56-65. PubMed ID: 30685413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excess of a Rassf1-targeting microRNA, miR-193a-3p, perturbs cell division fidelity.
    Pruikkonen S; Kallio MJ
    Br J Cancer; 2017 May; 116(11):1451-1461. PubMed ID: 28449010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
    Chen H; Pan H; Qian Y; Zhou W; Liu X
    Mol Cancer; 2018 Jan; 17(1):4. PubMed ID: 29310680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
    Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
    J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis.
    Mak CS; Yung MM; Hui LM; Leung LL; Liang R; Chen K; Liu SS; Qin Y; Leung TH; Lee KF; Chan KK; Ngan HY; Chan DW
    Mol Cancer; 2017 Jan; 16(1):11. PubMed ID: 28095864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.